Default Category
-
Coke and Pepsi in 2010 (Spanish version)
Yoffie, David B.; Kim, ReneeCase HBS-713S14StrategyCoke and Pepsi in 2010' case examines the industry structure and competitive strategy of Coca-Cola and Pepsi over 100 years of rivalry. The most intense battles of the cola wars were fought over the $74 billion CSD industry in the United States, where the average American consumes 46 gallons of CSD per year. In a "carefully waged competitive struggle," from 1975 to the mid-1990s, both Coke and Pepsi had achieved average annual growth of around 1...Starting at €8.20
-
Tale of Two Electronic Components Distributors (Spanish Version)
Raman, Ananth; Rao, Bharat P.Case HBS-604S15Service and Operations ManagementDiscute el papel de los intermediarios de distribución en la industria de componentes electrónicos, y describe las operaciones en dos de estos distribuidores. Sirve como un vehículo para discutir las funciones proporcionadas por los distribuidores en el canal. También permite a los estudiantes a entender las diferencias entre los distribuidores y discutir cómo cada uno de ellos va a hacer frente a cuestiones como la consolidación y el rápido crec...Starting at €8.20
-
Improving the Patient Experience (Spanish version)
Raman, Ananth; Tucker, AnitaCase HBS-615S02Service and Operations ManagementHealthcare has traditionally focused on medical outcomes and financial performance. The big question is always, "How much is it going to cost?" What would happen, though, if healthcare also considered the question of "How does the patient feel?" This case looks at the Cleveland Clinic's attempt to answer the latter question by attempting to institutionalize empathy as part of its delivery of care.Starting at €8.20
-
Coke vs. Pepsi in the 1990s (Spanish version)
Yoffie, David B.; Foley, SharonCase HBS-703S09StrategyThe competition between Coke and Pepsi is a classic corporate battle that began in America at the turn of the century and has expanded into worldwide competitive warfare in the 1990s. This case examines the economics of the soft drink and bottling industries, and describes the history and internationalization of the cola wars.Starting at €8.20
-
Las guerras de los navegadores, 1994-1998
Yoffie, David B.; Kwak, MaryCase HBS-705S21StrategyAnaliza la competencia entre Netscape y Microsoft en el mercado de los navegadores web y productos relacionados. A pesar de su ventaja de ser el primero, Netscape ve su cuota de mercado una vez caída Microsoft se convierte en "núcleo duro" de la Internet. En la primavera de 1998, el futuro de ambas empresas está en la línea.Starting at €8.20
-
Coke and Pepsi in 2006 (Spanish version)
Yoffie, David B.; Slind, MichaelCase HBS-707S06StrategyExamines the industry structure and competitive strategy of Coca-Cola and Pepsi over 100 years of rivalry. New challenges in 2006 include boosting flagging carbonated soft drink (CSD) sales and finding new revenue streams. Both firms also began to modify their bottling, pricing, and brand strategies. They looked to emerging international markets to fuel growth and broaden their portfolios of alternate beverages like tea, juice, sports drinks, ene...Starting at €8.20
-
Wal-Mart entra en México
Yoffie, David B.; Ginns, Jonathan J.Case HBS-715S20Strategyplanes iniciales del introduce Wal-Mart para entrar en el mercado minorista mexicana. Diseñado para su uso con las operaciones de descuento Wal-Mart Stores'.Starting at €8.20
-
Apple Inc. in 2015 (Spanish version)
Yoffie, David B.; Baldwin, EricCase HBS-716S05StrategyAt the end of 2014, Apple Inc. recorded the most profitable quarter of any firm in history, and its market capitalization soon topped $700 billion. 'Apple Inc in 2015' explores the history of Apple, its successes under Jobs, its continued growth under Tim Cook, and the challenges facing the company in 2015. With iPod sales continuing their freefall, tablet sales in decline, and the Macintosh's market share remaining small, Apple was increasingly ...Starting at €8.20
-
Merck: Investing in Science-Based Business (Abridged)
Raman, Ananth; Maurer, IngaCase HBS-611027-EService and Operations ManagementRay Gilmartin faces a dilemma. His company's credibility has been damaged by the recent withdrawal of Vioxx, a multi-billion dollar drug. Moreover, the withdrawal of Vioxx would imply that Merck would fail to meet analysts' earnings expectations for 2005 unless Gilmartin cuts the R&D budget. Cutting the budget might hurt morale and productivity in Merck labs.Starting at €8.20
-
Cleveland Clinic: Improving the Patient Experience
Raman, Ananth; Tucker, AnitaCase HBS-612031-EService and Operations ManagementHealthcare has traditionally focused on medical outcomes and financial performance. The big question is always, "How much is it going to cost?" What would happen, though, if healthcare also considered the question of "How does the patient feel?" This case looks at the Cleveland Clinic's attempt to answer the latter question by attempting to institutionalize empathy as part of its delivery of care.Starting at €8.20